Zebhauser, P. T., Cordts, I., Hengel, H., Haslinger, B., Lingor, P., Akman, H. O., Haack, T. B., & Deschauer, M. (2022). Characterization of cognitive impairment in adult polyglucosan body disease. Journal of Neurology, 269(6), 2854–2861. https://doi.org/10.1007/s00415-022-10960-z

Angevaare, M. J., Vonk, J. M. J., Bertola, L., Zahodne, L., Watson, C. W.-M., Boehme, A., Schupf, N., Mayeux, R., Geerlings, M. I., & Manly, J. J. (2022). Predictors of Incident Mild Cognitive Impairment and Its Course in a Diverse Community-Based Population. Neurology, 98(1). https://doi.org/10.1212/wnl.0000000000013017

Berry, K., Duarte‐Rojo, A., Grab, J. D., Dunn, M. A., Boyarsky, B. J., Verna, E. C., Kappus, M. R., Volk, M. L., McAdams‐DeMarco, M., Segev, D. L., Ganger, D. R., Ladner, D. P., Shui, A., Tincopa, M. A., Rahimi, R. S., & Lai, J. C. (2021). Cognitive Impairment and Physical Frailty in Patients With Cirrhosis. Hepatology Communications, 6(1), 237–246. https://doi.org/10.1002/hep4.1796

Shu, C., Green Snyder, L., Shen, Y., & Chung, W. K. (2021). Imputing cognitive impairment in SPARK, a large autism cohort. Autism Research, 15(1), 156–170. Portico. https://doi.org/10.1002/aur.2622

Lazar, R. M., Wadley, V. G., Myers, T., Jones, M. R., Heck, D. V., Clark, W. M., Marshall, R. S., Howard, V. J., Voeks, J. H., Manly, J. J., Moy, C. S., Chaturvedi, S., Meschia, J. F., Lal, B. K., Brott, T. G., & Howard, G. (2021). Baseline Cognitive Impairment in Patients With Asymptomatic Carotid Stenosis in the CREST-2 Trial. Stroke, 52(12), 3855–3863. https://doi.org/10.1161/strokeaha.120.032972

Borkowski, K., Taha, A. Y., Pedersen, T. L., De Jager, P. L., Bennett, D. A., Arnold, M., Kaddurah-Daouk, R., & Newman, J. W. (2021). Serum metabolomic biomarkers of perceptual speed in cognitively normal and mildly impaired subjects with fasting state stratification. Scientific Reports, 11(1). https://doi.org/10.1038/s41598-021-98640-2

Yang, Y., Liang, F., Gao, J., Dong, Y., Zhang, Y., Yang, G., Soriano, S. G., Feng, H.-J., & Xie, Z. (2021). Testosterone attenuates sevoflurane-induced tau phosphorylation and cognitive impairment in neonatal male mice. British Journal of Anaesthesia, 127(6), 929–941. https://doi.org/10.1016/j.bja.2021.08.028

Clouston, S. A. P., Hall, C. B., Kritikos, M., Bennett, D. A., DeKosky, S., Edwards, J., Finch, C., Kreisl, W. C., Mielke, M., Peskind, E. R., Raskind, M., Richards, M., Sloan, R. P., Spiro, A., Vasdev, N., Brackbill, R., Farfel, M., Horton, M., Lowe, S., … Luft, B. J. (2021). Cognitive impairment and World Trade Centre-related exposures. Nature Reviews Neurology, 18(2), 103–116. https://doi.org/10.1038/s41582-021-00576-8

Gardener, H., Levin, B., DeRosa, J., Rundek, T., Wright, C. B., Elkind, M. S. V., & Sacco, R. L. (2021). Social Connectivity is Related to Mild Cognitive Impairment and Dementia. Journal of Alzheimer’s Disease, 84(4), 1811–1820. https://doi.org/10.3233/jad-210519

Brenowitz, W. D., Zeki Al Hazzouri, A., Vittinghoff, E., Golden, S. H., Fitzpatrick, A. L., & Yaffe, K. (2021). Depressive Symptoms Imputed Across the Life Course Are Associated with Cognitive Impairment and Cognitive Decline. Journal of Alzheimer’s Disease, 83(3), 1379–1389. https://doi.org/10.3233/jad-210588

Pelgrim, T. A. D., Beran, M., Twait, E. L., Geerlings, M. I., & Vonk, J. M. J. (2021). Cross-sectional associations of tau protein biomarkers with semantic and episodic memory in older adults without dementia: A systematic review and meta-analysis. Ageing Research Reviews, 71, 101449. https://doi.org/10.1016/j.arr.2021.101449

Pyne, J. D., & Brickman, A. M. (2021). The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline. Neurodegenerative Diseases, 21(1–2), 1–23. Portico. https://doi.org/10.1159/000518581